30/06/2020
https://m.facebook.com/story.php?story_fbid=919032871843334&id=358953197851307
இந்தியாவின் முதல் கோவிட 19 தடுப்பூசி, ஹைதெராபாத் யை மையமாக கொண்ட பாரத் பையோடெக் ICMR உடன் சேர்த்து உருவாகியுள்ளது.. மனிதர்களுக்கான சோதனை ஜூலை முதல் தொடங்க உள்ளது...
India's first covid19 vaccine, covaxin to be developed by hyderabad-based Bharat Biotech gets DCGI approval; human trials to begin in July!!!
New Delhi: A potential COVID-19 vaccine, the first to be developed in India, has been given DCGI (Drug Controller General of India) approval for Phase I and II human clinical trials that are scheduled to start across the country in July.
Developed by Hyderabad-based Bharat Biotech, in association with ICMR (Indian Council for Medical Research), COVAXIN is an inactivated vaccine, created from a strain of the infectious SARS-CoV-2 virus, that has shown promise in preclinical studies, demonstrating extensive safety and effective immune responses.
Drug manufacturers around the world are racing to develop a vaccine against the novel coronavirus; a novel virus is one that has never previously been identified in humans, making the task of creating a vaccine that much harder.
